Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)
Author(s):
Fontein, D.B.Y.; Charehbili, A.; Nortier, J.W.R.; Putter, H.; Kranenbarg, E.M.K.; Kroep, J.R.; Linn, S.C.; Velde, C.J.H. van de (0000-0003-0104-1800)
Published
2017
Publication type
Article / Letter to editor
Breast cancerAdverse eventsAromatase inhibitorsHot flushes
Date issued
2017-04-30
Language
English
Is part of
EJSO - European Journal of Surgical Oncology (2017), Vol. 43, no. 4, p. 619-624
